Related references
Note: Only part of the references are listed.Modulation of Paracellular-like Drug Transport across an Artificial Biomimetic Barrier by Osmotic Stress-Induced Liposome Shrinking
Jonas Borregaard Eriksen et al.
PHARMACEUTICS (2022)
Current challenges and future perspectives in oral absorption research: An opinion of the UNGAP network
Zahari Vinarov et al.
ADVANCED DRUG DELIVERY REVIEWS (2021)
Exploring impact of supersaturated lipid-based drug delivery systems of celecoxib on in vitro permeation across Permeapad® membrane and in vivo absorption
Alexandra-Roxana Ilie et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2020)
Investigations of the mechanism behind the rapid absorption of nano-amorphous abiraterone acetate
Orsolya Basa-Denes et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2019)
Successful oral delivery of poorly water-soluble drugs both depends on the intraluminal behavior of drugs and of appropriate advanced drug delivery systems
Ben J. Boyd et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2019)
Drug permeability profiling using cell-free permeation tools: Overview and applications
Philippe Berben et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2018)
The artificial membrane insert system as predictive tool for formulation performance evaluation
Philippe Berben et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2018)
PermeaLoop (TM), a novel in vitro tool for small-scale drug-dissolution/permeation studies
Daniel Sironi et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2018)
Dynamic dissolution-/permeation-testing of nano- and microparticle formulations of fenofibrate
Daniel Sironi et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2017)
A novel microdialysis-dissolution/permeation system for testing oral dosage forms: A proof-of-concept study
Sophia Yui Kau Fong et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2017)
Evaluation of a dynamic dissolution/permeation model: Mutual influence of dissolution and barrier-flux under non-steady state conditions
Daniel Sironi et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2017)
Surfactants enhance recovery of poorly soluble drugs during microdialysis sampling: Implications for in vitro dissolution-/permeation-studies
Sebastian Koplin et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2017)
Absorptive Dissolution Testing of Supersaturating Systems: Impact of Absorptive Sink Conditions on Solution Phase Behavior and Mass Transport
Siddhi S. Hate et al.
MOLECULAR PHARMACEUTICS (2017)
FimH Antagonists: Phosphate Prodrugs Improve Oral Bioavailability
Simon Kleeb et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Rapid conversion of the ester prodrug abiraterone acetate results in intestinal supersaturation and enhanced absorption of abiraterone: In vitro, rat in situ and human in vivo studies
Jef Stappaerts et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2015)
An analysis of the attrition of drug candidates from four major pharmaceutical companies
Michael J. Waring et al.
NATURE REVIEWS DRUG DISCOVERY (2015)
What Is the Mechanism Behind Increased Permeation Rate of a Poorly Soluble Drug from Aqueous Dispersions of an Amorphous Solid Dispersion?
Kerstin J. Frank et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2014)
Impact of FaSSIF on the solubility and dissolution-/permeation rate of a poorly water-soluble compound
Kerstin J. Frank et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2012)
Drug precipitation-permeation interplay: Supersaturation in an absorptive environment
Jan Bevernage et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2012)
Amorphous solid dispersion enhances permeation of poorly soluble ABT-102: True supersaturation vs. apparent solubility enhancement
Kerstin J. Frank et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2012)
In-vitro permeability screening of melt extrudate formulations containing poorly water-soluble drug compounds using the phospholipid vesicle-based barrier
Johanna Kanzer et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2010)
Evaluation of in Vitro Models for Screening Alkaline Phosphatase-Mediated Bioconversion of Phosphate Ester Prodrugs
Haodan Yuan et al.
DRUG METABOLISM AND DISPOSITION (2009)
The influence of lead discovery strategies on the properties of drug candidates
Gyoergy M. Keserue et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
Comparison of drug transporter gene expression and functionality in Caco-2 cells from 10 different laboratories
Rose Hayeshi et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2008)
Parallel monitoring of plasma and intraluminal drug concentrations in man after oral administration of fosamprenavir in the fasted and fed state
Joachim Brouwers et al.
PHARMACEUTICAL RESEARCH (2007)
In vitro behavior of a phosphate ester prodrug of amprenavir in human intestinal fluids and in the Caco-2 system: Illustration of intraluminal supersaturation
Joachim Brouwers et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2007)
Preclinical pharmacology and pharmacokinetics of GW433908, a water-soluble prodrug of the human immunodeficiency virus protease inhibitor amprenavir
ES Furfine et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Absorption rate limit considerations for oral phosphate prodrugs
T Heimbach et al.
PHARMACEUTICAL RESEARCH (2003)
Simulated intestinal fluid as transport medium in the Caco-2 cell culture model
F Ingels et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2002)
Share Paper
